2018, BioTech, Medical Billing and Medicare

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

BioTech

Medical Billing

Medicare

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

84% of Americans told the Foundation that they were concerned about how much health care costs will affect them in the future, with 42% of patients saying they couldn’t afford to pay over $500 for an unexpected medical bill. Hospital costs contribute to rising medical costs to 49% of health consumers.

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

JANUARY 18, 2019

First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective. As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. and 300,000 people worldwide.

BioTech

BioTech Medicare Medical Billing Patient Experience

Connected Health Pulse

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Stay Connected